Paclitaxel Prodrugs: Toward Smarter Delivery of Anticancer Agents
- 8 November 2006
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (25), 7253-7269
- https://doi.org/10.1021/jm0602155
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Development of first photoresponsive prodrug of paclitaxelBioorganic & Medicinal Chemistry Letters, 2006
- Enhancement of the Therapeutic Efficacy of Taxol by the Mitogen-Activated Protein Kinase Kinase Inhibitor CI-1040 in Nude Mice Bearing Human HeterotransplantsCancer Research, 2005
- Polymeric anticancer drugs with pH-controlled activationAdvanced Drug Delivery Reviews, 2004
- Recent developments in antitumour taxoidsExpert Opinion on Therapeutic Patents, 2003
- Kinetics of paclitaxel 2′-N-methylpyridinium mesylate decompositionAAPS PharmSciTech, 2003
- Combined Modality Therapy of A431 Human Epidermoid Cancer Using Anti-EGFr Antibody C225 and RadiationCancer Biotherapy & Radiopharmaceuticals, 1999
- Synthesis and antitumor evaluation of paclitaxel phosphonooxymethyl ethers: a novel class of water soluble paclitaxel pro-drugsBioorganic & Medicinal Chemistry Letters, 1996
- Highly water soluble taxol derivatives: 2′-polyethyleneglycol esters as potential prodrugsBioorganic & Medicinal Chemistry Letters, 1994
- Trigonal Symmetry as a Host Design Element: Novel Conformation of Dodecakis(3,5‐dimethyl‐phenylthio)coronene in its 1,4‐Dioxane ClathrateAngewandte Chemie-International Edition, 1994
- Photocyclization of aryl-substituted acetylenesi application of di-.pi.-methane-like rearrangements to arylcyclopropene synthesesJournal of the American Chemical Society, 1971